Amarin Corporation PLC (NASDAQ:AMRN)

16.13
Delayed Data
As of Oct 18
 -0.26 / -1.59%
Today’s Change
11.78
Today|||52-Week Range
23.91
+18.52%
Year-to-Date
Why Amarin Investors Have Their Eyes on Nov. 14
Oct 13 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close16.39
Today’s open16.39
Day’s range16.02 - 16.52
Volume3,615,230
Average volume (3 months)7,961,402
Market cap$5.8B
Data as of 4:00pm ET, 10/18/2019

Growth & Valuation

Earnings growth (last year)-54.77%
Earnings growth (this year)+42.82%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)+25.01%
P/E ratioNM
Price/Sales17.68
Price/Book40.31

Competitors

 Today’s
change
Today’s
% change
SYNHSyneos Health Inc-0.34-0.61%
PRAHPRA Health Sciences ...-0.51-0.52%
EXELExelixis Inc-0.58-3.41%
CRLCharles River Labora...-1.79-1.32%
Data as of 6:30pm ET, 10/18/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$228.8M
Annual profit (last year)-$116.2M
Net profit margin-50.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts